4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050222
Director sold 10,200 shares at $0.67 ($6,834)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-22 | Sale : show line 1 in the form 10b5-1 | −10,200 | $0.67 | $6,834 | 274,773 | D |
| Open-market sales · 10,200 sh · avg $0.67 · $6,834 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-19 | Grant or award : show line 2 in the form 10b5-1 Stock Option | +85,000 | 85,000 | D |
Loading xslF345X05/doc4.xml…